LIM
AGN

Leavell Investment Management’s Allergan plc AGN Stock Holding History

Leavell Investment Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-10,289
Closed -$2.76M – 395
2016
Q1 		$2.76M Sell
10,289
-300
-3% -$85.9K 0.41% 73
2015
Q4 		$3.31M Buy
10,589
+30
+0.3% +$8.93K 0.49% 51
2015
Q3 		$2.87M Sell
10,559
-8
-0.1% -$2.46K 0.45% 61
2015
Q2 		$3.21M Buy
10,567
+643
+6% +$192K 0.5% 54
2015
Q1 		$2.95M Buy
9,924
+624
+7% +$178K 0.45% 63
2014
Q4 		$2.39M Buy
9,300
+6,800
+272% +$1.7M 0.37% 82
2014
Q3 		$603K Buy
2,500
+1,500
+150% +$336K 0.1% 211
2014
Q2 		$223K Buy
+1,000
New +$207K 0.04% 376

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Leavell Investment Management's AGN Position: Q2 2016 in Review

Leavell Investment Management sold out of Allergan plc (AGN) in Q2 2016, closing a stake of 10,289 shares — an estimated $2.76M sold.

Leavell Investment Management first reported a position in AGN in Q2 2014 and held it in 8 quarters. The position peaked at $3.31M in Q4 2015. 1,107 funds tracked by Wall St. Rank hold AGN as of Q2 2016.

  • Leavell Investment Management reported no remaining Allergan plc position as of Q2 2016 after selling out during the quarter.
  • Leavell Investment Management sold 10,289 Allergan plc shares in Q2 2016, an estimated $2.76M.
  • Leavell Investment Management first reported a position in Allergan plc in Q2 2014 and held it in 8 quarters.
  • Leavell Investment Management's Allergan plc position peaked at $3.31M in Q4 2015.
  • 1,107 funds tracked by Wall St. Rank held Allergan plc as of Q2 2016.

Based on Leavell Investment Management's 13F filing for Q2 2016, filed 18 Jul 2016.